DEMENTIA IN 2010 Paving the way for Alzheimer disease drug development

被引：6

作者：

Blennow, Kaj ^{[1
]}

机构：

[1] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Inst Neurosci & Physiol,Clin Neurochem Lab, SE-43180 Molndal, Sweden

来源：

NATURE REVIEWS NEUROLOGY | 2011年 / 7卷 / 02期

关键词：

PROTEIN;

D O I：

10.1038/nrneurol.2010.214

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Advances in alzheimer disease (ad) research during 2010 have identified promising novel diagnostic tools and therapeutic targets for this condition, and suggest that amyloid-beta immunotherapy reduces plaque load in patients with ad. a new lexicon for ad has also been proposed.

引用

页码：65 / 66

页数：2

共 8 条

[1] Alzheimer's disease [J].

Scheltens, Philip ;

De Strooper, Bart ;

Kivipelto, Miia ;

Holstege, Henne ;

Chetelat, Gael ;

Teunissen, Charlotte E. ;

Cummings, Jeffrey ;

van der Flier, Wiesje M. .

LANCET, 2021, 397 (10284) :1577-1590

[2] Research criteria for the diagnosis of Alzheimer"s disease: revising the NINCDS-ADRDA criteria [J].

Dubois, Bruno ;

Feldman, Howard H. ;

Jacova, Claudia ;

Dekosky, Steven T. ;

Barberger-Gateau, Pascale ;

Cummings, Jeffrey ;

Delocourte, Andre ;

Galasko, Douglas ;

Gauthier, Serge ;

Jicha, Gregory ;

Meguro, Kenichi ;

O'Brien, John ;

Pasquier, Florence ;

Robert, Philippe ;

Rossor, Martin ;

Solloway, Steven ;

Stern, Yaakov ;

Visser, Pieter J. ;

Scheltens, Philip .

LANCET NEUROLOGY, 2007, 6 (08) :734-746

[3] Revising the definition of Alzheimer's disease: a new lexicon [J].

Dubois, Bruno ;

Feldman, Howard H. ;

Jacova, Claudia ;

Cummings, Jeffrey L. ;

DeKosky, Steven T. ;

Barberger-Gateau, Pascale ;

Delacourte, Andre ;

Frisoni, Giovanni ;

Fox, Nick C. ;

Galasko, Douglas ;

Gauthier, Serge ;

Hampel, Harald ;

Jicha, Gregory A. ;

Meguro, Kenichi ;

O'Brien, John ;

Pasquier, Florence ;

Robert, Philippe ;

Rossor, Martin ;

Salloway, Steven ;

Sarazin, Marie ;

de Souza, Leonardo C. ;

Stern, Yaakov ;

Visser, Pieter J. ;

Scheltens, Philip .

LANCET NEUROLOGY, 2010, 9 (11) :1118-1127

[4] High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients [J].

Fukumoto, Hiroaki ;

Tokuda, Takahiko ;

Kasai, Takashi ;

Ishigami, Noriko ;

Hidaka, Hiroya ;

Kondo, Masaki ;

Allsop, David ;

Nakagawa, Masanori .

FASEB JOURNAL, 2010, 24 (08) :2716-2726

[5] Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives [J].

Hampel, Harald ;

Frank, Richard ;

Broich, Karl ;

Teipel, Stefan J. ;

Katz, Russell G. ;

Hardy, John ;

Herholz, Karl ;

Bokde, Arun L. W. ;

Jessen, Frank ;

Hoessler, Yvonne C. ;

Sanhai, Wendy R. ;

Zetterberg, Henrik ;

Woodcock, Janet ;

Blennow, Kaj .

NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (07) :560-574

[6] Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease [J].

He, Gen ;

Luo, Wenjie ;

Li, Peng ;

Remmers, Christine ;

Netzer, William J. ;

Hendrick, Joseph ;

Bettayeb, Karima ;

Flajolet, Marc ;

Gorelick, Fred ;

Wennogle, Lawrence P. ;

Greengard, Paul .

NATURE, 2010, 467 (7311) :95-U129

[7] 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study [J].

Rinne, Juha O. ;

Brooks, David J. ;

Rossor, Martin N. ;

Fox, Nick C. ;

Bullock, Roger ;

Klunk, William E. ;

Mathis, Chester A. ;

Blennow, Kaj ;

Barakos, Jerome ;

Okello, Aren A. ;

de Llano, Sofia Rodriguez Martinez ;

Liu, Enchi ;

Koller, Martin ;

Gregg, Keith M. ;

Schenk, Dale ;

Black, Ronald ;

Grundman, Michael .

LANCET NEUROLOGY, 2010, 9 (04) :363-372

[8]

Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782

← 1 →